The Administrative Core of the Tri-lnstitutional TBRU will organize and coordinate all aspects of TBRU activities. The Administrative Core will be led jointly by the Pls, Dr. Cari Nathan and Dr. Michael Glickman. The combined expertise of the Pls encompasses much of the scope of science that is proposed in this TBRU, including mycobacteriology, immunology, molecular biology, and clinical mycobacteriology. The Administrative Core includes a Data Management Center (DMC) that will leverage preexisting NIH funded computing infrastructure to manage clinical data, sample collection, sample tracking, and distribution. The DMC will employ a full time PhD level scientist in the central role of Data Coordinator and a Biostatistician. The Data Coordinator will coordinate and control all aspects of sample distribution, sample naming and data collection, and help arrange higher level data analysis with the statistical and computational biology resources that are affiliated with this Administrative Core. In addition to the DMC, the Administrative Core will manage communications between the Tri-I TBRU and NIAID staff, and between Tri-I TBRU and its External Advisory Group. We will closely monitor progress of the 5 TBRU projects and the Clinical Core through setting and benchmarking milestones, reviewing quarterly progress reports, and holding monthly meetings of the TBRU Project and Core Directors. These meetings will require no travel, because all TBRU investigators are based within one block of each other in New York City.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
1U19AI111143-01
Application #
8726606
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
1
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Weill Medical College of Cornell University
Department
Type
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10065
Ocheretina, Oksana; Byrt, Erin; Mabou, Marie-Marcelle et al. (2016) False-positive rifampin resistant results with Xpert MTB/RIF version 4 assay in clinical samples with a low bacterial load. Diagn Microbiol Infect Dis 85:53-5
Warrier, Thulasi; Kapilashrami, Kanishk; Argyrou, Argyrides et al. (2016) N-methylation of a bactericidal compound as a resistance mechanism in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 113:E4523-30
Glickman, Michael S; Schluger, Neil (2016) Adding Insult to Injury: Exacerbating TB Risk with Smoking. Cell Host Microbe 19:432-3
Gold, Ben; Smith, Robert; Nguyen, Quyen et al. (2016) Novel Cephalosporins Selectively Active on Nonreplicating Mycobacterium tuberculosis. J Med Chem 59:6027-44
Lupoli, Tania J; Fay, Allison; Adura, Carolina et al. (2016) Reconstitution of a Mycobacterium tuberculosis proteostasis network highlights essential cofactor interactions with chaperone DnaK. Proc Natl Acad Sci U S A 113:E7947-E7956
Nathan, Carl (2015) What can immunology contribute to the control of the world's leading cause of death from bacterial infection? Immunol Rev 264:2-5
Nathan, Carl; Barry 3rd, Clifton E (2015) TB drug development: immunology at the table. Immunol Rev 264:308-18
Ocheretina, Oksana; Shen, Lishuang; Escuyer, Vincent E et al. (2015) Whole Genome Sequencing Investigation of a Tuberculosis Outbreak in Port-au-Prince, Haiti Caused by a Strain with a ""Low-Level"" rpoB Mutation L511P - Insights into a Mechanism of Resistance Escalation. PLoS One 10:e0129207
Gold, Ben; Roberts, Julia; Ling, Yan et al. (2015) Rapid, Semiquantitative Assay To Discriminate among Compounds with Activity against Replicating or Nonreplicating Mycobacterium tuberculosis. Antimicrob Agents Chemother 59:6521-38
Severe, Linda; Fitzgerald, Daniel W; Deschamps, Marie M et al. (2014) ""I am proud of myself, just the way I am"" (Mwen fyé de tét mwen, jan mwen ye ya): a qualitative study among young Haitian women seeking care for sexually transmitted infections (STIs) in Haiti. AIDS Educ Prev 26:158-69